The UK Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit has issued a statement saying it endorses the new WHO recommendations on missed combined oral contraceptives (OCs).

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1488, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The UK Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit has issued a statement saying it endorses the new WHO recommendations on missed combined oral contraceptives (OCs).

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The UK Medicines Control Agency has issued a new safety update for bupropion

By  

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) advises that, as new data show an interaction between lamotrigine and oral contraceptives (OCs)

By  

Reactions Weekly, Vol. 1, Iss. 1062, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Amgen Inc. has issued a `Dear Health Care Professional' letter advising of important changes to the labelling for Aranesp

By  

Reactions Weekly, Vol. 1, Iss. 1035, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Sanofi-aventis has issued a `Dear Health Care Professional' letter outlining changes to the Ketek [telithromycin] label

By  

Reactions Weekly, Vol. 1, Iss. 1145, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite